News from upsher-smith laboratories, inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

May 16, 2016, 09:00 ET Upsher-Smith Announces Start Of First In Human Clinical Trial In Oncology With Novel CXCR4 Antagonist USL311

 Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced that it has commenced the first clinical study of its novel small molecule...


Apr 25, 2016, 09:05 ET ANDROXY™ (Fluoxymesterone Tablets, USP) CIII Available Exclusively Through Upsher-Smith

 Upsher-Smith Laboratories, Inc. (Upsher-Smith) announced that ANDROXY™ (Fluoxymesterone Tablets, USP) CIII are available for...


Apr 18, 2016, 09:00 ET Research Presented At 68th Annual Meeting Of The American Academy of Neurology Estimates That More Than One Million U.S. Emergency Department Visits Annually Are Related To Epilepsy

A cohort study using 2008-2011 data from the National Hospital Ambulatory Medical Care Survey found that seizure emergencies accounted for more...


Feb 11, 2016, 09:00 ET Upsher-Smith Recognizes Outstanding Achievements Of 43 U.S. Pharmacists

 Upsher-Smith Laboratories, Inc. (Upsher-Smith) has partnered with the National Alliance of State Pharmacy Associations (NASPA) to honor...


Jan 20, 2016, 09:17 ET Upsher-Smith And Saniona Sign Collaboration Agreement For Development Of Novel Therapeutics For Neurological Disorders

 Upsher-Smith Laboratories, Inc. (Upsher-Smith), through its wholly-owned subsidiary Proximagen Ltd., and Saniona, a leading biotech company in...


Dec 07, 2015, 09:00 ET Upsher-Smith Presents Data Evaluating PK, PD And Tolerability Of Investigational Midazolam Nasal Spray In Healthy Geriatric And Non-Geriatric Adults

 Upsher-Smith Laboratories, Inc., today announced that Phase 1 clinical trial data from USL261 (midazolam nasal spray) in healthy geriatric and...


Dec 07, 2015, 09:00 ET Seizure Clusters Significantly Impact Quality Of Life For Patients And Their Caregivers, According To A Landmark Survey Conducted By Harris Poll

 Results from a nationwide survey that measured the physical and emotional impact of seizure clusters, a seizure pattern experienced by some...


Dec 01, 2015, 01:15 ET Roche And Upsher-Smith Announce License Agreement To Develop Novel VAP-1 Inhibitor

 Roche and Upsher-Smith Laboratories, Inc. (Upsher-Smith), through its wholly-owned UK subsidiary Proximagen Ltd., today announced a worldwide...


Nov 23, 2015, 09:00 ET Upsher-Smith To Present New Data On Qudexy® XR (topiramate) Extended-Release Capsules And USL261 (Investigational Intranasal Midazolam)

 Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced that it will present nine posters at the 69th Annual Meeting of the American...


Nov 09, 2015, 09:00 ET Data Published In Epilepsia Shows USL261 (Intranasal Midazolam) Demonstrated A Promising Pharmacokinetic Profile, Including Increased Relative Bioavailability, When Compared With Injectable Midazolam Administered Intranasally

 Upsher-Smith Laboratories, Inc.'s, (Upsher-Smith) USL261 (intranasal midazolam), a novel, investigational midazolam formulation optimized for...


Oct 09, 2015, 09:00 ET Survey Reveals Burden Of Seizure Clusters On Children With Epilepsy And Their Caregivers

 Seizure clusters, a seizure pattern experienced by some patients with epilepsy, can have a profound impact on pediatric patients and their...


Aug 24, 2015, 09:00 ET Upsher-Smith Laboratories Names Rusty Field President

Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced that its Chief Commercial Officer, Rusty Field, has been named President of the...


Aug 10, 2015, 09:00 ET Upsher-Smith Receives FDA Approval For Generic Version Of Namenda® (Memantine HCl) Tablets

 Upsher-Smith Laboratories, Inc. (Upsher-Smith) announced that it has received U.S. Food and Drug Administration (FDA) approval of an...


Jul 27, 2015, 09:00 ET Upsher-Smith's ANDROXY™ (Fluoxymesterone Tablets, USP) CIII Now Available

Upsher-Smith Laboratories, Inc. (Upsher-Smith) announced that it has received U.S. Food and Drug Administration (FDA) approval of a supplemental...


Jun 01, 2015, 09:00 ET FDA Approves Expanded Indication For Qudexy® XR (Topiramate) Extended-Release Capsules Within The Pediatric Population

 Upsher-Smith Laboratories, Inc. (Upsher-Smith) announced that it has received U.S. Food and Drug Administration (FDA) approval of a...


Apr 21, 2015, 09:02 ET Upsher-Smith Research on Qudexy™ XR (topiramate) Extended-Release Capsules Highlighted at the 2015 American Academy of Neurology Annual Meeting

 Upsher-Smith Laboratories, Inc. (Upsher-Smith) presented data from a 52-week, open-label extension study (PREVAIL OLE) showing that...


Apr 13, 2015, 09:00 ET Upsher-Smith To Present Data Evaluating The Long-Term Safety And Efficacy Of Qudexy™ XR (Topiramate) Extended-Release Capsules And Alternative Administration Techniques

 Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced that it will present five posters at the 67th Annual Meeting of the American...


Apr 10, 2015, 11:25 ET Upsher-Smith To Debut I Hate Seizures™ Campaign At Ninth Annual National Walk For Epilepsy®

 I Hate Seizures is the message behind a new disease education campaign launched today by Upsher-Smith Laboratories, Inc. The campaign, to be...


Feb 24, 2015, 09:00 ET Upsher-Smith Honors 45 Innovative Pharmacists From Across The Nation

 Upsher-Smith Laboratories, Inc. (Upsher-Smith), is pleased to honor the 2014 recipients of the National Alliance of State Pharmacy...


Feb 10, 2015, 12:11 ET Upsher-Smith's Vogelxo™ (Testosterone) Gel 1% (Tubes and Packets) Receives AB-Rating To Testim® From FDA

Upsher-Smith Laboratories, Inc., (Upsher-Smith) today announced that it has received an AB (therapeutic equivalent) rating from the U.S. Food and...


Feb 09, 2015, 09:00 ET Upsher-Smith Launches Patient Savings And Support Program For Qudexy™ XR (Topiramate) Extended-Release Capsules

 Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced the availability of a new savings and support program for patients who have...


Dec 08, 2014, 09:00 ET Systematic Review Presented At 68th Annual Meeting Of The American Epilepsy Society Points To Need For Expert Consensus On Seizure Cluster Nomenclature And Diagnosis

 A new systematic review found that consistent and well-defined terminology to describe seizure clusters, a rare seizure pattern, is necessary...


Dec 08, 2014, 09:00 ET Upsher-Smith Presents New Data From Year-Long, Open-Label Extension Study Of Qudexy™ XR (Topiramate) Extended-Release Capsules At 68th Annual American Epilepsy Society Meeting

 Upsher-Smith Laboratories, Inc. (Upsher-Smith) presented findings from a year-long, open-label extension (OLE) study (PREVAIL OLE) of...


Nov 24, 2014, 09:00 ET Upsher-Smith To Present New Data At 2014 American Epilepsy Society Annual Meeting

 Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced that it will present seven abstracts at the 68th Annual Meeting of the American...


Oct 23, 2014, 10:30 ET Upsher-Smith Presents New Data On The Administration Of Qudexy™ XR (Topiramate) Extended-Release Capsules Through Enteral Feeding Tubes

 Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced the presentation of results from an in vitro study in which Qudexy™ XR...